MGE Energy Finalizes $240.6M Equity Offering and Forward Sale Agreements

summarizeSummary

MGE Energy finalized an equity offering of 3.3 million shares, with immediate proceeds of $72.19 million and an additional $168.42 million deferred through forward sale agreements, totaling $240.6 million in potential capital.

check_boxKey Events

• Definitive Underwriting Agreement Signed

  MGE Energy entered into an Underwriting Agreement on May 6, 2026, formalizing the public offering of its common stock.

• Initial Equity Offering Details

  The company immediately issued and sold 990,099 shares at a purchase price of $72.9094 per share, generating approximately $72.19 million in proceeds.

• Forward Sale Agreements Executed

  The offering includes 2,310,232 shares sold by forward sellers, with MGE Energy to receive proceeds upon settlement of related forward sale agreements, which can occur up to January 8, 2028. The initial forward sale price is $72.9094 per share.

• Potential Additional Shares

  Underwriters have an option to purchase up to 495,049 additional shares, which could be issued by the company, further increasing capital and dilution.

auto_awesomeAnalysis

MGE Energy has formalized a significant capital raise through an underwriting agreement and forward sale agreements. The company immediately sold 990,099 shares at $72.9094 per share, generating approximately $72.19 million in proceeds. Additionally, 2,310,232 shares were sold by forward sellers, with MGE Energy set to receive proceeds from these shares upon settlement of the forward sale agreements, which can extend until January 2028. The total potential proceeds from the initial offering, including the forward sales, amount to approximately $240.6 million. There is also an option for underwriters to purchase up to 495,049 additional shares, which could further increase the capital raised and dilution. The proceeds are earmarked for general corporate purposes, including debt repayment, capital expenditures, and investments in subsidiaries, providing financial flexibility. This offering, priced at a slight discount to the current market price while the stock trades near its 52-week low, represents a substantial capital infusion, potentially exceeding 10% of the company's market capitalization if all options are exercised and settled by the company.